Children with resistant leukemia given CRISPR-edited T cells: Phase 1 study results reported
MedicalXpress Breaking News-and-Events | Nov 01, 2022
A new treatment for acute myeloid leukemia could prove beneficial for even more people
MedicalXpress Breaking News-and-Events | Sep 17, 2022
Improving drug therapy for relapsed leukemia
MedicalXpress Breaking News-and-Events | Sep 16, 2022
Researchers identify a new class of drugs that offer a safer, more targeted treatment for leukemia patients
ScienceDaily | Aug 27, 2022
New study indicates people with current cancer diagnosis may face severe complications from COVID-19
MedicalXpress Breaking News-and-Events | Aug 18, 2022
Molecular map reveals insights into the genetic drivers of chronic lymphocytic leukemia
MedicalXpress Breaking News-and-Events | Aug 06, 2022
Leukemia vulnerability discovered causing drug sensitivity
ScienceDaily | Aug 03, 2022
Early study finds new lymphoma drug effective
Newswise | May 14, 2022
Researchers describe previously unknown risk factors for leukemia in adulthood
MedicalXpress Breaking News-and-Events | Apr 23, 2022
Ivosidenib + azacitidine ups event-free survival in IDH1-mutated acute myeloid leukemia
MedicalXpress Breaking News-and-Events | Apr 22, 2022